Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ZVRA compared with SCYX: revenue, margins and what each company keeps, and the suppliers and customers both name
ZVRA
Zevra Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SCYX
Scynexis Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ZVRA
Zevra Therapeutics, Inc.
vs
SCYX
Scynexis Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ZVRA
6
—
Aquestive Therapeutics
unlisted
supplier
—
Orphazyme A/S
unlisted
supplier
—
Relief
unlisted
supplier
—
Xoma
unlisted
supplier
2 more · ZVRA chain
›
Shared
0
No shared counterparties.
Only SCYX
4
—
Merck
unlisted
supplier
—
GlaxoSmithKline Intellectual Property (No. 3) Limited (GSK)
unlisted
customer
—
Hansoh
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
R-Pharm
unlisted
customer
ZVRA
Zevra Therapeutics, Inc.
Change
10.08
▼
−0.20%
· post 10.26
· delayed
Mkt cap
$599.8M
Revenue
$40M
Q2 FY26
Revenue
$106M
FY25
SCYX
Scynexis Inc
Change
3.93
▲
+3.22%
· post 3.93
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$37.5M
Revenue
$235,000
Q2 FY26
Revenue
$21M
FY25
vs
Compare
After hours
Nov 3 '26
delayed
ZVRA
Zevra Therapeutics, Inc.
vs
SCYX
Scynexis Inc
10.08
▼
−0.20%
post 10.26
delayed
Price
3.93
▲
+3.22%
post 3.93
delayed
$599.8M
Mkt cap
$37.5M
Q2 FY26
$40M
Revenue
$235,000
Q2 FY26
FY25
$106M
Revenue
$21M
FY25
Change
Change
ZVRA
10.08
▼
−0.20%
vs
SCYX
3.93
▲
+3.22%
After hours
Nov 3 '26
delayed